Nu Skin Reports Q4 & FY2025 Results with Continued Revenue Declines; Issues Weak 2026 Outlook

summarizeSummary

Nu Skin reported Q4 and full-year 2025 financial results within guidance, but with continued revenue declines and a weak outlook for 2026, despite strategic initiatives aimed at future growth.

check_boxKey Events

• Q4 2025 Revenue Decline

  Revenue for the fourth quarter of 2025 fell 16.9% to $370.3 million, or 10.4% excluding Mavely 2024 revenue, meeting guidance.

• Full-Year 2025 Revenue Decline

  Full-year 2025 revenue decreased 14.3% to $1.49 billion, also within the company's guidance range.

• Operational Metrics Weakness

  Key operational metrics for Q4 2025 showed significant declines: Customers decreased 10%, Paid Affiliates 11%, and Sales Leaders 19% year-over-year.

• Weak 2026 Outlook

  The company provided a weak outlook for 2026, projecting Q1 revenue of $320-$340 million (down 12-7%) and full-year EPS of $0.80-$1.20, which is below the 2025 adjusted EPS of $1.27.

auto_awesomeAnalysis

Nu Skin Enterprises reported fourth quarter and full-year 2025 financial results within its guidance, but the underlying trends show significant challenges. The company experienced substantial revenue declines in both periods, coupled with a notable decrease in key operational metrics such as customers, paid affiliates, and sales leaders, which are critical for its direct selling business model. While adjusted earnings for 2025 showed growth and margins improved, the outlook for Q1 and full-year 2026 indicates ongoing revenue pressure and a projected decrease in adjusted EPS compared to 2025. Investors should closely monitor the effectiveness of new strategic initiatives, including the global launch of Prysm iO and expansion into India, in reversing these persistent negative trends and achieving the forecasted return to revenue growth by year-end 2026.